
Nano-X Imaging (NNOX) Stock Forecast & Price Target
Nano-X Imaging (NNOX) Analyst Ratings
Bulls say
Nano X Imaging Ltd reported quarterly revenue of $3.4 million, marking an increase from $3.0 million in the previous quarter, driven by stronger teleradiology utilization and improved margins. The company secured a distribution agreement with Imperial Imaging Technology, expanding its commercial access to the Nanox.ARC system in six Southeastern states, thereby enhancing its point-of-care imaging model. Moreover, management confirmed its 2026 revenue guidance of $35 million, showcasing strong commercial traction and a commitment to scaling its installed base while highlighting recent FDA 510(k) clearance for new cloud-enabled technology as a key advancement.
Bears say
Nano X Imaging Ltd. reported a decline in cash reserves, with total cash decreasing to $55.5 million from $83.2 million, indicating a significant operational cash burn of $30.4 million and notable use of at-the-market (ATM) financing. The company's GAAP gross loss remained high at $2.9 million, underlining ongoing substantial expenditures for system deployments and AI infrastructure, while the net loss remained stable at $13.7 million. Although operational execution continues, the extended timelines and increased investments for development, regulatory approval, and commercialization have contributed to a negative outlook on the stock's future performance.
This aggregate rating is based on analysts' research of Nano-X Imaging and is not a guaranteed prediction by Public.com or investment advice.
Nano-X Imaging (NNOX) Analyst Forecast & Price Prediction
Start investing in Nano-X Imaging (NNOX)
Order type
Buy in
Order amount
Est. shares
0 shares